ROBIN YATES: Open Payments
NPI 1649982729 · EL RENO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 14 payments from 10 companies in 2025. Trend: 2023 $227 · 2024 $507 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Lundbeck LLC | 1 | $31 |
| Amgen Inc. | 2 | $29 |
| Organon LLC | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: VRAYLAR, Veozah, CAPLYTA, REXULTI, OTEZLA, NEXPLANON, FANAPT, Dexcom G6 Transmitter.
Industry payments across OK — which companies pay providers there.
